Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

These ovarian conditions cause high testosterone levels.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Certain drugs that block specific enzymes can help treat prostate diseases.